Disorders - Psychosis Disorders
Eack,
S., Newhill, C., Keshavan, M.
Objective: Cognitive remediation is emerging as an effective
psychosocial intervention for addressing untreated cognitive and functional impairments in persons with schizophrenia, and might achieve its benefits
through neuroplastic changes in brain connectivity. This study seeks to examine the effects of cognitive enhancement therapy (CET) on fronto-temporal
brain connectivity in a randomized controlled trial with individuals in the early course of schizophrenia. Method: Stabilized, early course
outpatients with schizophrenia or schizoaffective disorder (N = 41) were randomly assigned to CET (n = 25) or an active enriched supportive therapy
(EST) control (n = 16) and treated for 2 years. Functional MRI data were collected annually, and pseudo resting-state functional connectivity
analysis was used to examine differential changes in fronto-temporal connectivity between those treated with CET compared with EST. Results:
Individuals receiving CET evidenced significantly less functional connectivity loss between the resting-state network and the left dorsolateral
prefrontal cortex as well as significantly increased connectivity with the right insular cortex compared to EST (all corrected p < .01). These neural
networks are involved in emotion processing and problem-solving. Increased connectivity with the right insula significantly mediated CET effects on
improved emotion perception (z' = -1.96, p = .021), and increased connectivity with the left dorsolateral prefrontal cortex mediated CET-related
improvements in emotion regulation (z' = -1.71, p = .052). Conclusions: These findings provide preliminary evidence that CET, a psychosocial
cognitive remediation intervention, may enhance connectivity between frontal and temporal brain regions implicated in problem-solving and emotion
processing in service of cognitive enhancement in schizophrenia. (PsycINFO Database Record (c) 2016 APA, all rights reserved)
Journal of the Society for Social Work and Research, 7(2) : 211-
230
- Year: 2016
- Problem: Psychosis Disorders
- Type: Randomised controlled trials
-
Stage: Disorder established (diagnosed disorder), First episode (psychosis only)
-
Treatment and intervention: Psychological Interventions
(any), Cognitive remediation
therapy, Supportive
therapy
Cheng, S., Schepp, K.
Schizophrenia is a debilitating psychiatric disorder seen across the world. Recently, investigators have witnessed an
upsurge in research on the potential benefits of early intervention during the prodromal stage: the sooner people start the treatment at their first
psychotic episode, the better outcome on symptom relief and better functioning. This paper aims to critically review and synthesize empirical
evidence published between 2005 and 2015 regarding the effectiveness of preemptive interventions on transition rate, symptom severity, depression,
anxiety, and function level. Randomized controlled trials were identified in seven different electronic databases and twelve studies were included in
this review. Findings indicated that intervention was designed not only for help-seeking individuals, but also for their family members. Also, the
applications for psychiatric nursing are discussed. (PsycINFO Database Record (c) 2017 APA, all rights reserved)
Archives of Psychiatric Nursing, 30(6) : 774-
781
- Year: 2016
- Problem: Psychosis Disorders
- Type: Systematic reviews
-
Stage: At risk (indicated or selected prevention), First episode (psychosis only)
-
Treatment and intervention: Service Delivery & Improvement, Psychological Interventions
(any), Cognitive & behavioural therapies (CBT), Cognitive remediation
therapy, Family therapy, Other service delivery and improvement
interventions
Alvarez-Jimenez, M., O'Donoghue, B., Thompson, A., Gleeson, J., Bendall, S., Gonzalez-Blanch, C., Killackey, E., Wunderink, L., McGorry, P.
Treatment guidelines for first episode psychosis (FEP) recommend at least 1 year of
antipsychotic treatment following remission; however, in light of some recent research and the preference of some individuals to discontinue their
medication sooner, this recommendation can be questioned. The aim of this article is to appraise the current discontinuation studies given our views
on how this field should progress. We conducted a review of randomized controlled trials investigating dose-reduction/medication discontinuation
compared with treatment maintenance in clinically remitted FEP patients. Seven trials were identified, and these reported a higher rate of relapse in
the dose reduction or discontinuation groups. Relapse rates were higher when a lower threshold for relapse was utilized. However, only three studies
specified that concurrent psychosocial interventions were also provided, despite an evidence base for these interventions in reducing symptom
severity and relapse. Length of follow-up may also be important, as the study with the longest follow-up (7 years), albeit with some methodological
shortcomings, found greater functional recovery in the dose-reduction group and that relapse rates between the two groups (dose-reduction vs.
maintenance) were equal after 3 years. Finally, in addition to discontinuation or dose reduction, a diagnosis of schizophrenia, a longer duration of
illness, and poor premorbid functioning were associated with a greater risk of relapse. Further trials are needed in this area to establish the
long-term risk-benefit ratio of antipsychotic medication in FEP. Meanwhile, young people with FEP who do not fulfil criteria for a diagnosis of a
schizophrenia disorder, achieve clinical remission for at least 3 months, attain early functional recovery, and have good social support may be
possible candidates for discontinuation of antipsychotic medication bolstered by effective psychosocial interventions provided in the context of a
specialized FEP service. (PsycINFO Database Record (c) 2017 APA, all rights reserved)
CNS Drugs, 30(5) : 357-368
- Year: 2016
- Problem: Psychosis Disorders
- Type: Systematic reviews
-
Stage: First episode (psychosis only), Relapse prevention
-
Treatment and intervention: Biological Interventions
(any), Typical Antipsychotics (first generation), Atypical Antipsychotics (second
generation)
Chien, W., Thompson, D., Lubman, D., McCann, T.
Family interventions for
first-episode psychosis (FEP) are an integral component of treatment, with positive effects mainly on patients' mental state and relapse rate.
However, comparatively little attention has been paid to the effects of family interventions on caregivers' stress coping and well-being, especially
in non-Western countries. We aimed to test the effects of a 5-month clinician-supported problem-solving bibliotherapy (CSPSB) for Chinese family
caregivers of people with FEP in improving family burden and carers' problem-solving and caregiving experience, and in reducing psychotic symptoms
and duration of re-hospitalizations, compared with those only received usual outpatient family support (UOFS). A randomized controlled trial was
conducted across 2 early psychosis clinics in Hong Kong, where there might be inadequate usual family support services for FEP patients. A total of
116 caregivers were randomly selected, and after baseline measurement, randomly assigned to the CSPSB or UOFS. They were also assessed at 1-week and
6- and 12-month post-intervention. Intention-to-treat analyses were applied and indicated that the CSPSB group reported significantly greater
improvements in family burden and caregiving experience, and reductions in severity of psychotic symptoms and duration of re-hospitalizations, than
the UOFS group at 6- and 12-month follow-up. CSPSB produces moderate long-term benefits to caregivers and FEP patients, and is a low-cost adjunct to
UOFS. (PsycINFO Database Record (c) 2017 APA, all rights reserved)
Schizophrenia Bulletin, 42(6) : 1457-
1466
- Year: 2016
- Problem: Psychosis Disorders
- Type: Randomised controlled trials
-
Stage: First episode (psychosis only)
-
Treatment and intervention: Service Delivery & Improvement, Psychological Interventions
(any), Problem solving therapy (PST), Self-help, Other service delivery and improvement
interventions
Chang,
W., Kwong, V., Chan, G.,
Background: Functional remission (FR) is an intermediate and necessary step toward
recovery, but is understudied in first-episode psychosis (FEP). We aimed to examine the rate and predictors of FR in FEP patients in the context of a
randomized-controlled trial (RCT) comparing a 1-year extension of early intervention (Extended EI, 3-year EI) with step-down psychiatric care (SC, 2
-year EI). Methods: One hundred sixty Chinese patients were recruited from a specialized EI program for FEP in Hong Kong after they have completed
this 2-year EI service, randomly allocated to Extended EI or SC, and followed up for 12 months. Assessments on premorbid adjustment and personality,
clinical profiles, functioning, and treatment characteristics were conducted. FR was operationalized as simultaneous fulfillment of attaining
adequate functional levels (measured by Social and Occupational Functioning Scale and Role Functioning Scale) and competitive employment at 6 and 12
months. Data analysis was based on 156 subjects who completed follow-up functional assessments. Results: Thirty-one (19.9%) patients achieved FR
status. Multivariate binary regression analysis showed that female gender, lower degrees of premorbid schizoid-schizotypal traits, Extended EI
treatment condition, lower levels of positive symptoms at intake, and better baseline functioning independently predicted FR. Conclusion: This is the
first RCT providing supportive evidence to an extension of EI service beyond 2-year treatment duration on further enhancing the likelihood of FR
attainment in FEP. Our findings that only approximately 20% of patients achieved FR indicate an unmet therapeutic need for promoting sustained
adequate functional improvement in the early stage of psychotic illness. (PsycINFO Database Record (c) 2017 APA, all rights reserved)
Schizophrenia Research, 173(1-2) : 79-
83
- Year: 2016
- Problem: Psychosis Disorders
- Type: Randomised controlled trials
-
Stage: First episode (psychosis only)
-
Treatment and intervention: Service Delivery & Improvement, Case management, Other service delivery and improvement
interventions
Bergh, S., Hjorthoj, C., Sorensen, H. J., Fagerlund, B., Austin, S., Secher, R. G., Jepsen, J. R., Nordentoft, M.
Background Identifying baseline predictors of the long-term course of cognitive functioning in schizophrenia spectrum disorders is important
because of associations between cognitive functioning (CF) and functional outcome. Determining whether CF remains stable or change during the course
of illness is another matter of interest. Methods Participants from The Danish OPUS Trial, aged 18-45 years, with a baseline ICD-10 schizophrenia
spectrum diagnosis, were assessed on psychopathology, social and vocational functioning at baseline, and cognitive functioning 5 (N = 298) and 10
years (N = 322) after baseline. Uni- and multi-variable regression analyses of potential baseline predictors of 10-year CF were performed. Also,
changes in CF and symptomatology between 5 and 10 years of follow-up were assessed. Findings Baseline predictors of impaired CF after 10 years
included male gender, unemployment, poor premorbid achievement and later age of onset. Having finished high school and receiving early intervention
treatment was associated with better CF. Age, growing up with both parents, number of family and friends, primary caregivers education, premorbid
social function, negative symptoms, GAF (symptoms, function) and substance abuse, were associated with CF in univariable analyses. Non-participants
generally suffered from more severe dysfunction. Longitudinally, amelioration in negative symptoms was associated with improved speed of processing
and executive functions. Symptom scores generally improved with time, while scores for all cognitive tests remained stable. Conclusion The current
study identifies several robust associations between baseline characteristics and 10-year cognitive outcome. Several other variables were univariably
associated with 10-year cognitive outcome. Also, we found evidence for stability of CF over time. Copyright © 2016 Elsevier B.V.
Schizophrenia Research, 175(1-3) : 57-
63
- Year: 2016
- Problem: Psychosis Disorders
- Type: Randomised controlled trials
-
Stage: First episode (psychosis only)
-
Treatment and intervention: Service Delivery & Improvement, Other service delivery and improvement
interventions
Nuechterlein, K. H., Ventura, J., McEwen, S. C., Gretchen-Doorly, D., Vinogradov, S., Subotnik, Kenneth L
Schizophrenia
Bulletin, 42(suppl_1) : S44-S52
- Year: 2016
- Problem: Psychosis Disorders
- Type: Controlled clinical trials
-
Stage: First episode (psychosis only)
-
Treatment and intervention: Complementary & Alternative
Interventions (CAM), Psychological Interventions
(any), Cognitive remediation
therapy, Physical activity, exercise
Brewer, W.
J., Lambert, T. J., Witt, K., Dileo, J., Duff, C., Crlenjak, C., McGorry, P. D., Murphy, B. P.
Background: The first episode of psychosis is a crucial period when early intervention can alter the
trajectory of the young person's ongoing mental health and general functioning. After an investigation into completed suicides in the Early
Psychosis Prevention and Intervention Centre (EPPIC) programme, the intensive case management subprogramme was developed in 2003 to provide assertive
outreach to young people having a first episode of psychosis who are at high risk owing to risk to self or others, disengagement, or suboptimal
recovery. We report intensive case management model development, characterise the target cohort, and report on outcomes compared with EPPIC treatment
as usual. Methods: Inclusion criteria, staff support, referral pathways, clinical review processes, models of engagement and care, and risk
management protocols are described. We compared 120 consecutive referrals with 50 EPPIC treatment as usual patients (age 15-24 years) in a
naturalistic stratified quasi-experimental real-world design. Key performance indicators of service use plus engagement and suicide attempts were
compared between EPPIC treatment as usual and intensive case management, and psychosocial and clinical measures were compared between intensive case
management referral and discharge. Findings: Referrals were predominately unemployed males with low levels of functioning and educational attainment.
They were characterised by a family history of mental illness, migration and early separation, with substantial trauma, history of violence, and
forensic attention. Intensive case management improved psychopathology and psychosocial outcomes in high-risk patients and reduced risk ratings,
admissions, bed days, and crisis contacts. Interpretation: Characterisation of intensive case management patients validated the clinical research
focus and identified a first episode of psychosis high-risk subgroup. In a real-world study, implementation of an intensive case management stream
within a well-established first episode of psychosis service showed significant improvement in key service outcomes. Further analysis is needed to
determine cost savings and effects on psychosocial outcomes. Targeting intensive case management services to high-risk patients with unmet needs
should reduce the distress associated with pathways to care for patients, their families, and the community. Funding: National Health & Medical
Research Council and the Colonial Foundation.
Lancet Psychiatry, 2(1) : 29-37
- Year: 2015
- Problem: Psychosis Disorders, Suicide or self-harm behaviours (excluding non-suicidal self-harm), Suicide or self-harm with comorbid mental disorder
- Type: Controlled clinical trials
-
Stage: First episode (psychosis only), At risk (indicated or selected prevention)
-
Treatment and intervention: Service Delivery & Improvement, Case management
Calvo, A., Moreno, M., Ruiz-Sancho, A., Rapado-Castro, M., Moreno, C., Sanchez-Gutierrez, T., Arango, C., Mayoral, M.
Objective: To investigate whether the beneficial effects of a structured, psychoeducational, parallel-group program for
adolescents with early-onset psychosis and their families observed immediately after the intervention were maintained 2 years later. Method: The
present study examines the longitudinal efficacy of a randomized controlled trial based on a psychoeducational, problem-solving, structured group
intervention for adolescents with early-onset psychosis and their families (PE) and compares it with that of a nonstructured group intervention (NS)
after a 2-year follow-up. We analyzed whether the differences between PE and NS found after the intervention persisted 2 years later. Intergroup
differences in number and duration of hospitalizations, symptoms, and functioning were also assessed. Results: After 2 years of follow-up, we were
able to reassess 89% of patients. In the PE group, 13% of patients had visited the emergency department, compared with 50% in the NS group (p =
.019). However, no statistically significant differences were found between the groups for negative symptoms or number and duration of
hospitalizations. A significant improvement in Positive and Negative Syndrome Scale (PANSS) general symptoms was observed in the PE group.
Conclusion: Our psychoeducational group intervention showed sustained effects by diminishing the number of visits to emergency departments 2 years
after the intervention. Our findings indicate that this psychoeducational intervention could provide patients with long-lasting resources to manage
crises more effectively. (PsycINFO Database Record (c) 2016 APA, all rights reserved) (journal abstract).
Journal of
the American Academy of Child & Adolescent Psychiatry, 54(12) : 984-990
- Year: 2015
- Problem: Psychosis Disorders
- Type: Randomised controlled trials
-
Stage: First episode (psychosis only), Disorder established (diagnosed disorder)
-
Treatment and intervention: Psychological Interventions
(any), Family therapy, Psychoeducation, Problem solving therapy (PST)
Alphs, L., Bossie, C., Mao, L., Lee, E., Starr, H. L.
Aim: Long-acting injectable antipsychotics (APs) are not well studied in
recent-onset schizophrenia. This exploratory analysis of a study designed to reflect real-world schizophrenia, as defined by patients, interventions
and outcomes, compared relative treatment effect between once-monthly paliperidone palmitate (PP) and daily oral APs in patients with recent-onset or
chronic illness Methods: This randomized, open-label, event monitoring board-blinded study compared treatment response in subjects with schizophrenia
and a history of criminal justice system involvement following treatment with PP or oral APs for 15 months (ClinicalTrials.gov identifier,
NCT01157351). Event-free probabilities were estimated using Kaplan-Meier method; hazard ratios (HRs) were estimated using Cox proportional hazard
models. This subgroup analysis analysed data by disease duration (=5 (recent-onset) or >5 years (chronic illness) since first psychiatric diagnosis).
Results: Seventy-seven subjects met the criteria for recent-onset illness; 365 for chronic illness. HRs (95% CI) for treatment failure for oral APs
versus PP were 1.73 (0.87-3.45; P=0.121) for recent-onset and 1.37 (1.02-1.85; P=0.039) for chronic illness.
Early Intervention in
Psychiatry, :
- Year: 2015
- Problem: Psychosis Disorders
- Type: Randomised controlled trials
-
Stage: Disorder established (diagnosed disorder), First episode (psychosis only)
-
Treatment and intervention: Biological Interventions
(any), Typical Antipsychotics (first generation), Atypical Antipsychotics (second
generation)
Amminger, G. P., Schafer, M. R., Schlogelhofer,
M., Klier, C. M., McGorry, P. D.
Long-chain omega-3
polyunsaturated fatty acids (PUFAs) are essential for neural development and function. As key components of brain tissue, omega-3 PUFAs play critical
roles in brain development and function, and a lack of these fatty acids has been implicated in a number of mental health conditions over the
lifespan, including schizophrenia. We have previously shown that a 12-week intervention with omega-3 PUFAs reduced the risk of progression to
psychotic disorder in young people with subthreshold psychotic states for a 12-month period compared with placebo. We have now completed a longer-
term follow-up of this randomized, double-blind, placebo-controlled trial, at a median of 6.7 years. Here we show that brief intervention with
omega-3 PUFAs reduced both the risk of progression to psychotic disorder and psychiatric morbidity in general in this study. The majority of the
individuals from the omega-3 group did not show severe functional impairment and no longer experienced attenuated psychotic symptoms at follow-
up.
Nature
Communications, 6 :
- Year: 2015
- Problem: Psychosis Disorders
- Type: Randomised controlled trials
-
Stage: At risk (indicated or selected prevention)
-
Treatment and intervention: Complementary & Alternative
Interventions (CAM), Fish oil (Omega-3 fatty acids), Omega 3 fatty
acids (e.g. fish oil, flax oil)
Choi, J., Corcoran, C., Dixon, L., Javitt, D. C.
Background: Deficits in processing speed (PS) have found to be correlated with social aptitude in CHR
cohorts and variably identified as risk markers for psychosis. Among those with attenuated positive symptoms, processing speed has been related to
social and role functioning regardless of conversion to Sz. These information processing dysfunctions seem to be upstream to broader, top-down
cognitive and social skills. When subprocesses are degraded, the brain must adjust by lengthening space and time integration constants in effort to
detect relevant signals. This adaptation comes at a cost since the brain cannot accurately represent details of spatiotemporally complex signals.
This results in slowed speed of information processing in a social situation. We examined the feasibility of improving information processing
relevant to social situations in CHR, including its sustainability at 2 months, and its association with concurrent social function. Methods: This
was a double-blind RC T where 39 CHR participants were randomized to Processing Speed Training (PST) or an active control matched for training format
and the same dose and duration of treatment. PST is a tablet-based program that uses pupillometry to continually adjust training parameters for an
optimal cognitive load and improve visual scanning efficiency by inhibiting selection of non-essential targets and discriminating figure-ground
details. Results: The PST group showed faster motorical and non-motorical PS at post (F [2,35]=5.09, p=.00) and 2 months (F [4,31]=4.49, p=.01).
Subsequent results in social functioning at 2 month follow-up showed the PST group reporting better overall social adjustment (F [4,31]=3.72, p=.02)
and less anxiety about engaging in new social situations (F [4,31]=3.15, p=.02). Of note, changes in PS from baseline to 2 months were correlated
with overall social adjustment (r=.28-.39, p=.00-.02) and social avoidance (r=.29, p=.01) regardless of group assignment. Furthermore, processing
speed at baseline predicted social adjustment outcome at 2 mo, even after accounting for variance attributable to group assignment and symptoms
(R2=.49, F [4,31]=4.60; p=.01). Conclusion: To our knowledge, this is the first study to test focal cognitive training for PS deficits in a
putatively prodromal phase of Sz to address social morbidity. Targeting PS appears to be a promising pathway to improving co-morbidity and mitigating
a risk factor for psychosis.
Schizophrenia Bulletin, 41 : S41
- Year: 2015
- Problem: Psychosis Disorders
- Type: Randomised controlled trials
-
Stage: At risk (indicated or selected prevention)
-
Treatment and intervention: Psychological Interventions
(any), Cognitive remediation
therapy